£520.00

It has never been this cheap. We have no record of a lower price.

£520 today · cheaper than every other day in the last 3 months

2023-2028 US Cancer Screening Outlook - Market Study

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 87 days · 87 data points (no recent data)

Historical
Generating forecast…
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 11 August 2026 01 September 2026 23 September 2026 14 October 2026 05 November 2026
View at Amazon ↗

Price data checked 4 days ago

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 87 days • 1 price levels

Days at Price
87 days 0 22 44 65 87 £520 Days at Price

Price Analysis

Most common price: £520 (87 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 87 days

Description

This comprehensive study provides a detailed outlook for cancer screenings across the United States from 2023 to 2028. By analyzing latent demand, the report offers potential industry earnings (P.I.E.) estimates in millions of U.S. dollars for approximately 12,600 cities. Users can access comparative benchmarks that report the percent share of each city relative to its state and the entire United States. This statistical approach allows for quick comparisons between different geographic locations. These insights are designed to support effective distribution and sales force strategies through the use of econometric models.

Key Features

Provides latent demand outlooks for cancer screenings across various U.S. states and cities through 2028.

Includes potential industry earnings (P.I.E.) estimates in millions of U.S. dollars for 12,600 cities.

Offers comparative benchmarks by reporting each city's percent share of its state and the United States.

Supports sales force and distribution strategies using detailed econometric models.

Allows for quick geographic gauging by comparing city data against national and state-level benchmarks.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
09 November 2022

Similar Products You Might Like

The 2023-2028 Outlook for Cancer Testing-Screening in the United States
99% match

The 2023-2028 Outlook for Cancer Testing-Screening in the United States

£520.00 30 Sep 2026
The 2023-2028 Outlook for Cancer Testing-Screening in India
99% match

The 2023-2028 Outlook for Cancer Testing-Screening in India

£515.00 01 Oct 2026
US Cancer Supportive Care Outlook 2023-2028 Study Report
99% match

US Cancer Supportive Care Outlook 2023-2028 Study Report

£520.00 07 Nov 2026
The 2025-2030 World Outlook for Cancer Screenings
98% match

The 2025-2030 World Outlook for Cancer Screenings

Price unavailable
US Cancer Diagnostics Lab Test Outlook 2023-2028 Study
98% match

US Cancer Diagnostics Lab Test Outlook 2023-2028 Study

£520.00 06 Nov 2026
Cancer Supportive Care Drugs Outlook 2023-2028 Report
98% match

Cancer Supportive Care Drugs Outlook 2023-2028 Report

£520.00 06 Nov 2026
India Cancer Supportive Care Drugs Outlook 2023-2028
98% match

India Cancer Supportive Care Drugs Outlook 2023-2028

£515.00 06 Nov 2026
The 2023-2028 Outlook for Cancer Testing-Screening in China
98% match

The 2023-2028 Outlook for Cancer Testing-Screening in China

£495.00 02 Oct 2026
The 2023-2028 Outlook for Cancer Testing-Screening in Japan
98% match

The 2023-2028 Outlook for Cancer Testing-Screening in Japan

£495.00 02 Oct 2026
World Outlook for Cancer Specialty Hospitals 2025-2030
98% match

World Outlook for Cancer Specialty Hospitals 2025-2030

Price unavailable
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
98% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£520.00 30 Sep 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
98% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India

£515.00 30 Sep 2026
The 2021-2026 World Outlook for Cancer Biomarkers
98% match

The 2021-2026 World Outlook for Cancer Biomarkers

£795.00 06 Nov 2026
US Cancer Screening Outlook 2023-2028 - Zip Code Study
98% match

US Cancer Screening Outlook 2023-2028 - Zip Code Study

£490.00 24 Aug 2026
The 2023-2028 Outlook for Cancer Vaccines in the United States
98% match

The 2023-2028 Outlook for Cancer Vaccines in the United States

£520.00 02 Oct 2026
2023-2028 US Breast Cancer Screening Outlook Study
98% match

2023-2028 US Breast Cancer Screening Outlook Study

£520.00 07 Nov 2026
The 2023-2028 Outlook for Cancer Vaccines in India
98% match

The 2023-2028 Outlook for Cancer Vaccines in India

£515.00 01 Oct 2026
India Lung Cancer Screening Software Outlook 2023-2028
98% match

India Lung Cancer Screening Software Outlook 2023-2028

£515.00 06 Nov 2026
Uterine Cancer Therapeutics and Diagnostics Outlook 2023-2028
98% match

Uterine Cancer Therapeutics and Diagnostics Outlook 2023-2028

£520.00 06 Nov 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in the United States
98% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in the United States

£520.00 01 Oct 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in India
98% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancers in India

£515.00 01 Oct 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in China
98% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in China

£495.00 23 Sep 2026
US Breast Cancer Diagnostic Products Outlook 2023-2028
98% match

US Breast Cancer Diagnostic Products Outlook 2023-2028

£520.00 06 Nov 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in India
98% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in India

£515.00 02 Oct 2026